Studio Disfruta SRL
Studio Disfruta reported total assets of €1.14m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Oct 2025).
The score of Studio Disfruta shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +61 % Total assets +1476 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Studio Disfruta's annual accounts
Filed annual accounts
- Year ended 31 Mar 2025filed on 31 Oct 2025
- Year ended 31 Mar 2024filed on 30 Nov 2024
- Year ended 31 Mar 2023filed on 23 Nov 2023
- Year ended 31 Mar 2022filed on 03 Nov 2022
- Year ended 31 Mar 2021filed on 24 Jan 2022
Studio Disfruta's financial analysis
- Solvency2.7%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Studio Disfruta
Studio Disfruta's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0745.965.335
- VAT number
- BE0745965335
- Peppol
- Registered · 0208:0745965335 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Apr 2020
- Registered office
- 2630 Aartselaar
- Latest accounts
- 2025 · filed on 31 Oct 2025
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Studio Disfruta (SRL) has been based in Aartselaar since 2020, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 9,478 € and equity of 30,811 €; its revenue is not published. Its solvency stands at 2.7%, below the median of its sector (46.0%).
Companies similar to Studio Disfruta
Companies in the same business, of comparable size and area, outside its group.
- Tristel Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €1.88m
- F Care Systems Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €3.15m
- Schwabe Pharma Belgium Wholesale of pharmaceutical and medical goods Kontich · balance sheet €3.13m
- ALL-in-1 Wholesale of pharmaceutical and medical goods Schelle · balance sheet €8.97m
- Biotechnological Enzymatic Catalyse Wholesale of pharmaceutical and medical goods Merelbeke-Melle · balance sheet €1.22m
- Medicor International Wholesale of pharmaceutical and medical goods Rotselaar · balance sheet €1.45m
- MedXPress.Pro Wholesale of pharmaceutical and medical goods Leuven · balance sheet €1.46m
- Extraphar Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 10,258 €
Frequently asked questions about Studio Disfruta
What is the revenue of Studio Disfruta?
Studio Disfruta files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Studio Disfruta?
In Belgium, the VAT number is the company number prefixed with BE: BE0745965335 for Studio Disfruta, if the company is VAT-registered. Its company number (CBE) is 0745.965.335.
Where is the registered office of Studio Disfruta?
According to the CBE register, the registered office of Studio Disfruta is in 2630 Aartselaar.
What is the equity of Studio Disfruta?
At the close of the 2025 financial year, the equity of Studio Disfruta amounts to 30,811 €, a solvency of 2.7% of total assets.
Who manages Studio Disfruta?
The register lists 2 active mandates at Studio Disfruta. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Studio Disfruta
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →